Type 2 Diabetes with New Neuropathic Symptoms: Medication and OMT Considerations
A 62-year-old woman with a 10-year history of type 2 diabetes presents with a 2-month history of burning pain and numbness in both feet. Her current medications include metformin 1000 mg twice daily and glipizide 5 mg daily. Her most recent HbA1c is 8.2%. On exam, she has decreased sensation to light touch and vibration in a stocking distribution up to the mid-calf. She has a positive standing flexion test on the right and restricted motion in the lower thoracic and lumbar spine. She is interested in non-pharmacologic options for her pain.
1. What is your pharmacologic and non-pharmacologic management plan for her neuropathic pain, considering her diabetes control?
Read the worked answer
First, optimize glycemic control by intensifying diabetes therapy. Her HbA1c is above goal; consider adding a GLP-1 receptor agonist or SGLT2 inhibitor, or adjusting current medications. For neuropathic pain, first-line agents include gabapentin or pregabalin, or a tricyclic antidepressant (e.g., amitriptyline) or serotonin-norepinephrine reuptake inhibitor (e.g., duloxetine). Start at low dose and titrate. Non-pharmacologic options include OMT to address somatic dysfunction, which may improve circulation and reduce pain through musculoskeletal balancing. Also recommend regular exercise, foot care, and possibly physical therapy. Avoid opioids. Patient education on foot inspection is crucial.
2. What OMT techniques might you use for her, and what precautions are necessary given her diabetes?
Read the worked answer
OMT can address the somatic dysfunction in her lower thoracic and lumbar spine. Techniques such as soft tissue massage, myofascial release, and muscle energy are appropriate to improve mobility and reduce pain. However, precautions include avoiding vigorous manipulative techniques that could cause skin damage or discomfort due to peripheral neuropathy. Check skin integrity before and after treatment. Also, because she has diabetes, she may have autonomic neuropathy; monitor for orthostatic hypotension during positional changes. Avoid HVLA if she has osteoporosis or severe neuropathy. Coordinate with her diabetes management to ensure blood glucose is stable during sessions.